Skip to main content
All lobbying filings

GRIFOLS SHARED SERVICES NORTH AMERICA, INC.

Lobbying for GRIFOLS SHARED SERVICES NORTH AMERICA INC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $390,000.00 expenses · posted Jul 16, 2025

Official filing document

 Bills named in this filing 12
  • HR 1476
    PLASMA Act
  • S 694
    PLASMA Act
  • HR 1143
    Medicare IVIG Access Enhancement Act of 2025
  • HR 2343
    John W. Walsh Alpha-1 Home Infusion Act of 2025
  • HR 2172
    Preserving Patient Access to Home Infusion Act
  • S 1818
    Prescription Drug Price Relief Act of 2025
  • HR 3546
    Prescription Drug Price Relief Act of 2025
  • S 1587
    Fair Prescription Drug Prices for Americans Act
  • HR 3375
    Fair Prescription Drug Prices for Americans Act
  • S 1753
    End Price Gouging for Medications Act
  • HR 3493
    Global Fairness in Drug Pricing Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 4
Health Issues

H.R. 1476 / S. 694, Preserving Life-Saving Access to Specialty Medicines in America Act (PLASMA Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program H.R. 1143, Medicare IVIG Access Enhancement Act of 2025 H.R. 2343 , John W. Walsh Alpha-1 Home Infusion Act of 2025 H.R. 2172, Preserving Patient Access to Home Infusion Act S. 1818 / H.R.3546, Prescription Drug Price Relief Act of 2025 S.1587 / H.R.3375, Fair Prescription Drug Prices for Americans Act S.1753, End Price Gouging for Medications Act H.R. 3493, Global Fairness in Drug Pricing Act

Immigration

Issues related to immigration policy

Budget/Appropriations

FY2026 Appropriations bill for Health and Human Services; Medicare and Medicaid drug pricing and eligibility FY2026 Appropriations bill for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Blood Safety and Pathogen Reduction H.R. 1, One Big, Beautiful Bill Act; Medicare provisions - Most Favored Nations and drug pricing, Medicaid provisions - PBM Reform and eligibility, R&D tax credits

Tariff (miscellaneous tariff bills)

Issues related to tariff policy; tariffs on pharmaceuticals and related products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem